Home » Topics » Regulatory

Regulatory
RSS

FDA approves anthracycline with orphan drug status for carcinoma in situ of the bladder

Oct. 5, 1998

First MMP inhibitor cleared for marketing as adjunct in periodontitis

Oct. 2, 1998

A novel use described for the proton pump inhibitor pantoprazole

Sep. 30, 1998

Genentech's Herceptin given FDA approval

Sep. 28, 1998

Expanded approval requested for chemoprotective agent

Sep. 24, 1998

Antidepressant efficacy demonstrated with amantadine

Sep. 23, 1998

Wealth of clinical data support efficacy of ziprasidone

Sep. 23, 1998

FDA will give priority review to Nabi's reformulated H-BIG

Sep. 23, 1998

Another SSRI success story: sertraline safe and effective in patients with panic disorder

Sep. 23, 1998

Caroverine shown to effective treatment for alcohol withdrawal syndrome

Sep. 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 16, 2025.
Atai Therapeutics discovers new 5-HT2A receptor partial agonists
BioWorld Science
Atai Therapeutics Inc. has synthesized new tetrahydro pyridine-substituted indole and azaindoles acting as 5-HT2A receptor partial agonists reported to be useful...
PHD inhibitors reported in Akebia Therapeutics patent
BioWorld Science
Akebia Therapeutics Inc. has identified new derivatives of ([1,2,4]triazolo[5,1-a]isoquinoline-5-carbonyl)glycinate acting as prolyl 4-hydroxylase (PHD) inhibitors.
FDA wants more data for Otsuka’s sNDA in PTSD
BioWorld
The U.S. FDA is insisting that another study is needed to bolster the sNDA for Rexulti (brexpiprazole) from Otsuka Pharmaceutical Co. Ltd. in treating adults with...